What You Should Know:
- Celery, a financial operations platform leveraging artificial intelligence to automate internal controls secures $6.25M in seed funding led by Team8 Capital, with participation from Verissimo Ventures, Centre Street Partners, 97212 Ventures, and several strategic angel investors. This latest round brings Celery's total funding to $9M.
- The company was co-founded by Brot, a former startup CEO; Noam Slomianko, a serial entrepreneur and cybersecurity expert; and
Read More
Olio Secures $11M to Scale Care Coordination Platform
What You Should Know:
- Olio, a software platform dedicated to streamlining care coordination raises $11M in Series B funding round led by Fulcrum Equity Partners, with significant participation from Mutual Capital Partners (MCP), a growth equity firm specializing in scaling innovative healthcare and B2B software companies.
- This new capital infusion is earmarked to expand Olio's product offerings and accelerate its go-to-market initiatives, thereby deepening its impact on
Read More
Bioliberty Launches Lifehub Clinic with Soft-Robotic Lifeglov for Neurological Therapy
What You Should Know:
- Bioliberty, a medtech startup focused on revolutionizing the delivery of physical and occupational therapy, today announced the official launch of its first product, Lifehub Clinic.
- Lifehub Clinic is presented as an affordable and portable modular solution designed to assist therapists in delivering high-intensity, engaging therapy within clinical settings.
Soft-Robotic Wearables
This new system will serve as a central hub for Bioliberty's
Read More
Trump Signs Executive Order to Lower US Drug Prices with MFN Policy
What You Should Know:
- President Donald J. Trump has signed a new Executive Order aimed at bringing the prices Americans and U.S. taxpayers pay for prescription drugs in line with those paid by comparable developed nations.
- The executive order introduces a "Most-Favored-Nation" (MFN) pricing model and directs multiple government agencies to take action against what the Administration terms unfair international pricing practices that inflate costs for American
Read More
UPMC Enterprises, Redesign Health Launch Glimmer Health to Transform Chronic Pain Management in Primary Care
What You Should Know:
- Glimmer Health, a new company designed to empower primary care physicians with effective and comprehensive chronic pain management solutions, was officially unveiled today by UPMC Enterprises and Redesign Health. This marks the second innovative healthcare company funded and launched through the partnership between the venture capital arm of UPMC and the New York-based company creator.
- Glimmer Health aims to address the significant burden of chronic pain,
Read More
Mentaily Secures $3M for AI-Powered Mental Health Assessment Tool, LIV
What You Should Know:
- Mentaily, a company developing AI-powered tools for mental health assessment, triage, and the diagnosis of mental disorders secures $3M seed funding round led by a US-based family office and Israeli family offices, with significant participation from impact funds The Rashi Foundation and Sheatufim, alongside prominent digital health angel investors.
- Founded in 2024, Mentaily is focused on addressing complex mental health needs, particularly those emerging in
Read More
Omada Health Files for IPO
What You Should Know:
- Virtual care company Omada Health filed for an initial public offering (IPO) on Friday, according to the SEC filing.
- Founded in 2012, Omada specializes in virtual care programs designed to support patients managing chronic conditions such as prediabetes, diabetes, and hypertension.
- The company describes its unique approach as a “between-visit care model,” aiming to complement the broader healthcare ecosystem by providing ongoing support to
Read More
Aranscia Acquires Spesana to Advance Precision Oncology
What You Should Know:
- Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions announced its strategic acquisition of Spesana and its best-in-class suite of patient navigation, clinical collaboration, and oncology clinical decision support utilities.
- As part of the acquisition, Spesana’s Founder and CEO, Carla Balch, a renowned pioneer in healthcare and oncology information systems, will assume the role of Executive Director across
Read More
Ethical Implementation of AI in Mental Healthcare: A Practical Guide
The integration of Artificial Intelligence (AI) in mental healthcare presents transformative opportunities to enhance patient care while raising important ethical considerations.
As mental health providers increasingly adopt AI tools to improve their practice efficiency and patient outcomes, understanding how to implement these technologies ethically becomes crucial. The road to implementing AI can feel daunting and the options overwhelming, which is why it’s
Read More
AI Study Challenges Fears of Racial Bias in Prostate Cancer Care
What You Should Know:
- Artera, a company developing multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the publication of a significant validation study in the JCO Clinical Cancer Informatics.
- The study rigorously assessed Artera's MMAI model and confirmed its ability to perform similarly across different racial subgroups using data from diverse prostate cancer clinical trials.
Addressing the Challenge of AI Racial Bias
Read More
